
Healthcare and medicine · OncologyResearch and development · BiotechnologyResearch and development · Genetics
CRISPR makes prostate cancer immunotherapy more effective
Scientists have developed an experimental CRISPR-based technology that makes prostate tumors more susceptible to immune attack and increases the effectiveness of immunotherapy. This new approach could open up possibilities for treating other types of cancer that are difficult to manage with current therapies.
0 —
